TGFα is dispensable for skin tumorigenesis in Tg.AC mice

Toxicologic Pathology

Volumn 26, Issue 4, 1998, Pages 562-569

  Humble, Michael C ^a,c   Szczesniak, Carl J ^c   Luetteke, Noreen C ^a,b   Spalding, Judson W ^c   Cannon, Ronald E ^c   Hansen, Laura A ^d   Lee, David C ^a,b   Tennant, Raymond W ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epidermal growth factor receptor (EGFR); Oncogene; TPA; Transgenic mice; v Ha ras; Wounding

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; PAPILLOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TRANSGENE; TRANSGENIC MOUSE; WOUND HEALING;

ANIMALIA; MUS MUSCULUS;

EID: 0031824594     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600413     Document Type: Article

References (44)

1. Chomczynski P (1993). A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15: 532-537.
2. Chomczynski P and Sacchi N (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
3. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, and Shipley GD (1992). Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res. 52: 3224-3227.
4. Cox DR (1972). Regression models and life-tables. J. R. Stat. Soc. B34: 187-220.
5. Derynck R (1986). Transforming growth factor-α: Structure and biological activities. J. Cell. Biochem. 32: 293-304.
6. Derynck R (1988). Transforming growth factor α. Cell 54: 593-595.
7. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, and Berger WH (1987). Synthesis of messenger RNAs for transforming growth factors a and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47: 707-712.
8. Derynck R, Roberts AB, Winkler ME, Chen EY, and Goeddel DV (1984). Human transforming growth factor-α: Precursor structure and expression in E. coli. Cell 38: 287-297.
9. DiGiovanni J (1992). Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54: 63-128.
10. Ha-induced epidermal neoplasia: Potential involvement of alternative epidermal growth factor receptor ligands. Cancer Res. 55: 1883-1893.
11. Ha oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res. 57: 3180-3188.
12. Finzi E, Kilkenny A, Strickland JE, Balaschak M, Bringman T, Derynck R, Aaronson S, and Yuspa SH (1988). TGFα stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression. Mol. Carcinog. 1: 7-12.
13. Furstenberger G, Rogers M, Schnapke R, Bauer G, Hofler P, and Marks F (1989). Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int. J. Cancer 43: 915-921.
14. Hansen LA and Tennant RW (1994). Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic Tg.AC mice. Mol. Carcinog. 9: 143-156.
15. Higashiyama S, Abraham JA, Miller J, Fiddes JC, and Klagsburn M (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936-939.
16. Imamoto A, Beltran LM, and DiGiovanni J (1991). Evidence for autocrine/paracrine growth stimulation by transforming growth factor-α during the process of skin tumor promotion. Mol. Carcinog. 4: 52-60.
17. Jhappan C, Stahle C, Harkins RH, Fausto N, Smith GH, and Merlino GT (1990). TGFa overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137-1146.
18. Jhappan C, Takayama H, Dickerson RB, and Merlino G (1994). Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell. Growth Differ. 5: 385-394.
19. Jonckheere AR (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41: 133-145.
20. Kiguchi K, Beltran L, Dubowski A, and DiGiovanni J (1997). Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-α, and skin tumor promotion in wa-1 mice. J. Invest. Dermatol. 108: 784-791.
21. Kiguchi K, Beltran L, You J, Rho O, and DiGiovanni J (1995). Elevation of transforming growth factor-α mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol. Carcinog. 12: 225-235.
22. Leder A, Kuo A, Cardiff RD, Sinn E, and Leder P (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87: 9178-9182.
23. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, and Lee DC (1993). TGFa deficiency results in hair follicle and eye abnormalities in targeted and Waved-1 mice. Cell 73: 263-278.
24. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, and Dunn AR (1993). Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249-261.
25. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, and Klagsbrun M (1993). Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. USA 90: 3889-3893.
26. Marquardt H, Hunkapiller MW, Hood LE, and Todaro GJ (1984). Rat transforming growth factor type 1 structure and relation to epidermal growth factor. Science 223: 1079-1082.
27. Massague' J (1983). Epidermal growth factor-like transforming growth factor. J. Biol. Chem. 258: 13614-13620.
28. Massague' J (1990). Transforming growth factor-α: A model for membrane-anchored growth factors. J. Biol. Chem. 265: 21303-21396.
29. Matsui Y, Halter SA, Holt JT, Hogan BLM, and Coffey RJ (1990). Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 61: 1147-1155.
30. Rho O, Beltran LM, Gimenez-Conti IB, and DiGiovanni D (1994). Altered expression of the epidermal growth factor receptor and transforming growth factor-aα during multistage skin carcinogenesis in SENCAR mice. Mol. Carcinog. 11: 19-28.
31. Salomon DS, Kim N, Saeki T, and Ciardiello F (1990). Transforming growth factor α: An oncodevelopmental growth factor. Cancer Cells 2: 389-397.
32. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, and Lee DC (1990). Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121-1135.
33. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, and Lee DC (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell Biol. 13: 320-330.
34. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igaradhi K, and Folkman J (1993). Betacellulin: A mitogen from pancreatic β cell tumors. Science 259: 1604-1607.
35. Shoyab M, Plowman GD, McDonald VL, Bradley JG, and Todaro GJ (1989). Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 243: 1074-1076.
36. Siegel S (1956). Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York, pp. 116-127.
37. Spalding JW, Momma J, Elwell MR, and Tennant RW (1993). Chemically induced skin carcinogenesis in a transgenic mouse line (Tg.AC) carrying a v-Ha-ras gene. Carcinogenesis 14: 1335-1341.
38. Tarone RE (1975). Tests for trend in life table analysis. Biometrika 62: 679-682.
39. Todaro GJ, De Larco JE, and Cohen S (1976). Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature 264: 26-31.
40. Todaro GJ, Fryling C, and De Larco JE (1980). Transforming growth factors produced by certain tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA 77: 5258-5262.
41. Vassar R and Fuchs E (1991). Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev. 5: 714-727.
42. Vaughn TJ, Paschall JC, and Brown KD (1992). Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem. J. 287: 681-684.
43. Watanabe T, Shintani A, Nakata M, Shing Y, Folkman J, Igarashi K, and Sasada R (1994). Recombinant human betacellulin. J. Biol. Chem. 269: 9966-9973.
44. Wong ST, Winchell LF, McCune BK, Earp HS, Teixido' J, Massague' J, Herman B, and Lee DC (1989). The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 56: 495-506.